Theoharis V Koftis

Title: Theoharis V Koftis: Innovator in Pharmaceutical Processes

Introduction

Theoharis V Koftis is a notable inventor based in Salonika, Greece. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel processes for drug preparation. With a total of 2 patents, his work has the potential to impact the pharmaceutical industry positively.

Latest Patents

One of his latest patents is titled "Process for the preparation of O-desmethyl-venlafaxine and salts thereof." This invention relates to a novel method for preparing O-desmethyl venlafaxine (ODV) and its pharmaceutically acceptable salts. The process involves the provision of a spiro-venlafaxine compound as an intermediate, converting this intermediate into ODV free base in a one-pot process, and optionally converting the ODV free base into pharmaceutically acceptable salts. Additionally, the invention includes novel processes for preparing crystalline salts of ODV-succinate and ODV-oxalate.

Another significant patent by Koftis is "Process for the preparation of a propenal intermediate and derivatives thereof." This invention provides an improved method for preparing (E)-N-(4-(4-fluorophenyl)-6-isopropyl-5-(3-oxoprop-1-enyl)pyrimidin-2-yl)-N-methyl methanesulfon-amide. This compound serves as a useful intermediate for the preparation of Rosuvastatin, a well-known medication.

Career Highlights

Theoharis V Koftis is associated with Pharmathen S.A., a company that specializes in the development and manufacturing of pharmaceutical products. His work at Pharmathen has allowed him to focus on innovative processes that enhance drug formulation and delivery.

Collaborations

Throughout his career, Koftis has collaborated with several professionals in the field. Notable coworkers include Ioanna Georgopoulou and Alexandros Strongilos, who have contributed to his research and development efforts.

Conclusion

Theoharis V Koftis is a distinguished inventor whose work in pharmaceutical processes has led to valuable patents. His contributions continue to shape the future of drug development and formulation.